{"id":1356,"date":"2026-03-12T09:12:00","date_gmt":"2026-03-12T08:12:00","guid":{"rendered":"https:\/\/www.nutrimedia.info\/?post_type=news&#038;p=1356"},"modified":"2026-03-09T21:13:32","modified_gmt":"2026-03-09T20:13:32","slug":"microbiota-fat-beige-thermogenesis","status":"publish","type":"news","link":"https:\/\/www.nutrimedia.info\/en\/news\/microbiote-graisse-beige-thermogenese\/","title":{"rendered":"Beige fat: when the intestinal microbiota does the work that diet alone cannot do"},"content":{"rendered":"<p><strong>Transforming white fat into beige fat - in other words, converting passive storage tissue into active thermogenic tissue - has been one of the Holy Grails of metabolic research for the last ten years. A study published in <em>Nature<\/em> by the teams of Kenya Honda and Ramnik Xavier has just shown that this is possible in mice. Not with a drug. With four bacterial strains and a low-protein diet. The mechanism involves a double signal via the liver, bile acids and the hormone FGF21. And there are human analogues.<\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Beige fat: a quick reminder for those who missed the course<\/strong><\/h2>\n\n\n\n<p><strong>White fat stores energy. Brown and beige fat dissipate it in the form of heat,<\/strong> via activation of UCP1 - a mitochondrial uncoupling protein. This \u00abbeige\u00bb state of white adipose tissue is associated with improved insulin sensitivity and reduced cardiometabolic risk.<\/p>\n\n\n\n<p>The problem: in adult humans, <strong>Active beige fat is rare,<\/strong> which varies from one individual to another, and which is difficult to induce in a sustainable way using conventional nutritional approaches. Hence the interest in understanding what activates it - and in particular what the <a href=\"https:\/\/www.nutrimedia.info\/en\/news\/can-the-brain-modify-the-microbiota\/\" data-type=\"news\" data-id=\"665\">intestinal microbiota<\/a> has to do with it.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Study design: axenic mice, bacterial consortia, controlled diet<\/strong><\/h2>\n\n\n\n<p>The team worked with three types of mouse model: conventional mice, axenic mice (with no microbiota, known as <em>germ-free<\/em>) and models colonised by defined bacterial consortia. All were fed either a standard diet or a low-protein diet.<\/p>\n\n\n\n<p><strong>First net result : <\/strong>the low-protein diet induced a marked increase in beige fat - but only in animals with a microbiota. In axenic mice on the same diet, there was no conversion. Protein restriction alone is not enough. The microbiota is a co-requisite.<\/p>\n\n\n\n<p>The researchers then identified four human bacterial strains capable, in association with this diet, of triggering the conversion of white adipose tissue, with induction of beige adipocytes expressing UCP1 in subcutaneous and visceral deposits.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>A two-signal system: bile, FXR, liver and FGF21<\/strong><\/h2>\n\n\n\n<p>This is the mechanistic core of the study - and the most interesting for B2B players.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>First signal:<\/strong> all four strains modify bile acid metabolism. This modification activates the FXR nuclear receptor in adipocyte progenitors, directing their transcriptional programme towards a thermogenic beige phenotype.<\/li>\n\n\n\n<li><strong>Second signal:<\/strong> these same bacteria produce ammonia. This ammonia stimulates the liver to secrete FGF21, a key hormone in energy metabolism, known for many years for its role in thermogenesis and insulin sensitivity. When the FGF21 pathway is genetically inactivated, conversion to beige fat disappears. Both signals are necessary. One without the other is not enough.<\/li>\n<\/ul>\n\n\n\n<p><strong>This intestine-liver-fatty tissue system is a two-key circuit. This type of redundant mechanism suggests biological robustness - and distinct entry points for intervention strategies.<\/strong><\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"572\" src=\"https:\/\/www.nutrimedia.info\/wp-content\/uploads\/2026\/03\/Graisse-beige-1024x572.jpg\" alt=\"Beige fat and microbiota\" class=\"wp-image-1350\" srcset=\"https:\/\/www.nutrimedia.info\/wp-content\/uploads\/2026\/03\/Graisse-beige-980x547.jpg 980w, https:\/\/www.nutrimedia.info\/wp-content\/uploads\/2026\/03\/Graisse-beige-480x268.jpg 480w\" sizes=\"(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1024px, 100vw\" \/><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Metabolic results in mice<\/strong><\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Parameter<\/strong><\/td><td><strong>Effect of the \u00ablow protein + 4 strains\u00bb combo\u00bb<\/strong><\/td><\/tr><tr><td>White fat<\/td><td>Reduction, partial conversion to beige fat<\/td><\/tr><tr><td>Thermogenesis (UCP1)<\/td><td>Increase in subcutaneous and visceral deposits<\/td><\/tr><tr><td>Body weight<\/td><td>Reduced weight gain vs. controls with comparable calorie intake<\/td><\/tr><tr><td>Blood glucose<\/td><td>Improved glucose tolerance and insulin sensitivity<\/td><\/tr><tr><td>Blood lipids<\/td><td>Lower cholesterol levels<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p><em>Sources: PMID 41781619; BusinessWire (03\/2026)<\/em><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>The human question: where do we stand in our knowledge of beige fat?<\/strong><\/h2>\n\n\n\n<p>The authors do not extrapolate lightly. But they have carried out a transposability test: transferring the microbiota of human volunteers with brown or beige fat activity confirmed by FDG-PET restores the ability to <em>browning<\/em> in axenic mice. Functionally analogous microbial signatures therefore exist in humans.<\/p>\n\n\n\n<p>This is not proof of clinical efficacy. It's a mechanistic proof of concept that justifies seeking out human data.<\/p>\n\n\n\n<p>As far as the limitations are concerned, the authors are clear: the low-protein diet used in mice falls short of the recommended intake for humans - it is not transposable nutritional advice as such. And previous attempts to <a href=\"https:\/\/www.nutrimedia.info\/en\/news\/probiotics-and-efsa-marketing-strategies-in-the-face-of-regulatory-challenges\/\" data-type=\"news\" data-id=\"460\">probiotics<\/a> \u00abThe results of clinically-tested \u00bbfat burners' have been disappointing. Methodological caution is called for.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>What this means for B2B ingredients and biotech players<\/strong><\/h2>\n\n\n\n<p>This study does not deliver an ingredient. It provides a mechanism. And well-understood mechanisms are what make it possible to build R&amp;D strategies based on real hypotheses - not bets.<\/p>\n\n\n\n<p><strong>Three concrete angles:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Identify precise pharmacological and nutritional targets.<\/strong> Intestinal FXR, FGF21 pathways, bile acid metabolism - these are documented targets, with existing literature, known molecules and regulatory precedents. Biotech and pharma players are already working on FXR agonists or FGF21 analogues; on the nutrition front, the question is which dietary substrates or prebiotics can direct the microbiota towards these four strains or their equivalent functional activity.<\/li>\n\n\n\n<li><strong>Think in terms of consortia rather than isolated strains.<\/strong> The effect observed here is linked to a consortium of four strains acting jointly on two distinct signals. This is yet another argument in favour of complex symbiotic approaches - selection of strains oriented towards metabolic function, combined with specific prebiotic matrices that favour their colonisation and biliary activity.<\/li>\n\n\n\n<li><strong>Segment target populations.<\/strong> The effect is conditional: it depends on both the diet and the initial microbiota. This type of result suggests the need for a more detailed analysis of populations - overweight people with a pro-inflammatory microbiota, metabolic patients with low FDG-PET beige fat activity - and for stratified clinical studies, not trials in an unselected general population.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>FAQ - What can we learn from this study on beige fat?<\/strong><\/h2>\n\n\n\n<p><strong>Can these four strains already be identified and produced on a large scale?<\/strong> The researchers characterised them as part of the study. Production at scale and the stability of the consortia in commercial formulations remain open questions - but these are engineering issues, not obstacles of principle. Specialised platforms (bioproduction of anaerobic consortia) already exist at several players.<\/p>\n\n\n\n<p><strong>FGF21 is also induced by fasting and exercise - does this change anything?<\/strong> Yes, and it's useful. This means that the FGF21 pathway is accessible via several inputs, including nutrition. Previous work shows that certain specific amino acids (notably methionine) and certain types of fibre modulate FGF21. This is a direct innovation angle for ingredient suppliers - without going through a severe low-protein diet.<\/p>\n\n\n\n<p><strong>Does this call into question high-protein diets for weight management?<\/strong> Not directly. The study does not compare a high-protein diet with a low-protein diet in a human clinical context. It shows that protein restriction, via the microbiota, can activate a thermogenic circuit - under very controlled conditions. This is not an argument against protein; it is an argument for understanding the effect of the protein\/microbiota ratio on the adipose phenotype.<\/p>\n\n\n\n<p><strong>Are these results published in a peer-reviewed journal?<\/strong> Yes, the study is published in <em>Nature<\/em> (PMID: 41781619), the journal with the highest impact in general sciences. The weight of evidence is solid for an animal study - which does not prejudge the results in human clinical trials.<\/p>\n\n\n\n<p><strong>How soon can we expect to see an ingredient or probiotic clinically validated on this basis?<\/strong> Full clinical validation of an ingredient or probiotic targeting this pathway would take 5 to 10 years under the usual conditions of controlled trials. But proof-of-concept studies in humans (FDG-PET + microbiota + nutritional intervention) could be carried out within 2 to 3 years by well-positioned players.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Video summary<\/h2>\n\n\n\n<figure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<iframe loading=\"lazy\" title=\"Reprogramming the metabolism - Beige fat\" width=\"1080\" height=\"608\" src=\"https:\/\/www.youtube.com\/embed\/RBxhE_mSJ3k?feature=oembed\"  allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>\n<\/div><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Sources<\/strong><\/h2>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Honda K., Xavier R. et al (2026). <em>Nature<\/em>, PMID : 41781619 - <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/41781619\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/41781619\/<\/a><\/li>\n\n\n\n<li>EurekAlert (03\/2026) : <a href=\"https:\/\/www.eurekalert.org\/news-releases\/1118424\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/www.eurekalert.org\/news-releases\/1118424<\/a><\/li>\n\n\n\n<li>Medical Xpress (03\/2026) : <a href=\"https:\/\/medicalxpress.com\/news\/2026-03-gut-bacteria-diet-reprogram-fat.html\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/medicalxpress.com\/news\/2026-03-gut-bacteria-diet-reprogram-fat.html<\/a><\/li>\n\n\n\n<li>BusinessWire (03\/2026) : <a href=\"https:\/\/www.businesswire.com\/news\/home\/20260304149113\/en\/Study-Reveals-How-Gut-Bacteria-and-Diet-Can-Reprogram-Fat-to-Burn-More-Energy\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/www.businesswire.com\/news\/home\/20260304149113\/en\/Study-Reveals-How-Gut-Bacteria-and-Diet-Can-Reprogram-Fat-to-Burn-More-Energy<\/a><\/li>\n\n\n\n<li>Keio University \/ Bio2Q (03\/2026) : <a href=\"https:\/\/bio2q.keio.ac.jp\/news\/research-20260304-honda\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/bio2q.keio.ac.jp\/news\/research-20260304-honda\/<\/a><\/li>\n\n\n\n<li>PMC - microbiota &amp; energy metabolism magazine : <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9901041\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9901041\/<\/a><\/li>\n\n\n\n<li>PubMed - Beige fat, UCP1 &amp; cardiometabolic risk :<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29486523\/\" target=\"_blank\" rel=\"noreferrer noopener\"> https:\/\/pubmed.ncbi.nlm.nih.gov\/29486523\/<\/a><\/li>\n<\/ol>\n\n\n\n<p><\/p>\n\n\n\n<p><strong>Are you working on microbiome-centric solutions for weight management or energy metabolism?<\/strong><\/p>\n\n\n\n<p>\u2192 <strong>Do you have a specific question?<\/strong> Our AI assistant can give you quick guidance:<a href=\"https:\/\/www.nutrimedia.info\/en\/nutrimedia-offers-and-packs\/#chat-avec-nutrimedia\"> Talking to the assistant<\/a><\/p>\n\n\n\n<p>\u2192 <strong>Need structured support?<\/strong> Find out more about our formats - from one-shots to editorial partnerships:<a href=\"https:\/\/www.nutrimedia.info\/en\/nutrimedia-offers-and-packs\/\"> See the offers<\/a><\/p>\n\n\n\n<p>\u2192 <strong>Would you like to discuss it in person?<\/strong> 30 minutes to define your needs, with no obligation:<a href=\"https:\/\/calendly.com\/nicolas-nutrimedia\/30min\" target=\"_blank\" rel=\"noopener\"> Reserve a slot<\/a><\/p>","protected":false},"template":"","meta":{"_acf_changed":true,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false},"class_list":["post-1356","news","type-news","status-publish","hentry"],"acf":[],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.nutrimedia.info\/en\/wp-json\/wp\/v2\/news\/1356","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.nutrimedia.info\/en\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.nutrimedia.info\/en\/wp-json\/wp\/v2\/types\/news"}],"wp:attachment":[{"href":"https:\/\/www.nutrimedia.info\/en\/wp-json\/wp\/v2\/media?parent=1356"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}